Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
January 2016 - 23 products
IP
CI
Arnuity Ellipta 90 mcg
30 unidose(s)
15.60
33.40
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Arnuity Ellipta 90 mcg
3 x 30
46.80
67.30
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Arnuity Ellipta 182 mcg
30 unidose(s)
25.58
44.25
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Arnuity Ellipta 182 mcg
3 x 30
76.74
99.90
10 %
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg
GlaxoSmithKline AG
B / SL
FB
G
L
IP
V/S
PP
Respreeza 50 mg/ml à 1 g
2
313.06
362.25
10 %
Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung: Alpha-1-Proteinasi Inhibitor Humanum 1000 mg
CSL Behring AG
B / SL
FB
G
L
IP
V/S
PP
Respreeza 50 mg/ml à 4 g
2
1252.22
1325.80
10 %
Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung: Alpha-1-Proteinasi Inhibitor Humanum 4000 mg
CSL Behring AG
B / SL
FB
G
IP
Pertector 2.3-57.1 GBq
Gerät
PR
PR
10 %
medeo AG
A / SL
FB
G
IP
Duosol 2 mmol/l K
2 x 5000 ml
PR
PR
k.A.
Hemofiltration solution: 5 Active Agents
Hemofiltration solution: 2 Active Agents
Hemofiltration solution: 5 Active Agents
B. Braun Medical SA
B
FB
G
IP
Duosol ohne K
2 x 5000 ml
PR
PR
k.A.
Hemofiltration solution: 4 Active Agents
Hemofiltration solution: 2 Active Agents
Hemofiltration solution: 4 Active Agents
B. Braun Medical SA
B
FB
G
IP
Vimizim 5mg/5ml
Durchstechflasche(n)
PR
PR
k.A.
Concentrate for infusion: Elosulfasum Alfa 5mg / 5ml
DRAC AG
B
FB
G
IP
CI
PP
Spedra 50 mg
4 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 50 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 50 mg
8 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 50 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 50 mg
12 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 50 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 100 mg
2 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 100 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 100 mg
4 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 100 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 100 mg
8 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 100 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 100 mg
12 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 100 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 200 mg
4 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 200 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 200 mg
8 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 200 mg
A. Menarini GmbH
B
FB
G
IP
CI
PP
Spedra 200 mg
12 Tablet(s)
PR
PR
k.A.
Tablets: Avanafilum 200 mg
A. Menarini GmbH
B
FB
G
IP
Arnuity Ellipta 46 mcg
30
PR
PR
k.A.
Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 46 µg
GlaxoSmithKline AG
B
FB
G
IP
Duosol 4 mmol/l K
2 x 5000 ml
PR
PR
k.A.
Hämoflitrationslösung: 2 Active Agents
Hämoflitrationslösung: 2 Active Agents
Hämoflitrationslösung: 5 Active Agents
B. Braun Medical SA
B
FB
G
CI
H
Ceres Viscum comp.
20 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 4 Active Agents
Ceres Heilmittel AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home